v3.25.4
Share-based compensation - Summary of Stock Option Activity (Details)
 9 Months Ended 12 Months Ended 48 Months Ended 72 Months Ended
Jan. 19, 2022
shares
Dec. 31, 2025
shares
$ / shares
Dec. 31, 2024
shares
$ / shares
Dec. 31, 2023
shares
$ / shares
Dec. 31, 2022
shares
$ / shares
Dec. 31, 2025
shares
$ / shares
Dec. 31, 2025
shares
$ / shares
2013 ISOP              
Changes In Equity Instruments, Number Of Equity Instruments, In Share-Based Payment Arrangement [Abstract]              
Outstanding at beginning of period (in shares)   560,980 606,980 657,980      
Granted (in shares)             0
Exercised (in shares)   (68,000) (32,000) (39,000)      
Forfeited (in shares)   (12,000) (14,000) (12,000)      
Outstanding at end of period (in shares)   480,980 560,980 606,980 657,980 480,980 480,980
Exercisable (in shares)   480,980 560,980 606,980   480,980 480,980
Changes In Equity Instruments, Weighted Average Exercise Price Of Equity Instruemnts, In Share-Based Payment Arrangement [Abstract]              
Outstanding at end of period (in dollars per share) | $ / shares   $ 3.18 $ 3.03 $ 3.00 $ 2.92 $ 3.18 $ 3.18
Exercised (in dollars per share) | $ / shares   1.96 3.16 2.52      
Forfeited (in dollars per share) | $ / shares   3.17 1.75 0.05      
Outstanding at beginning of period (in dollars per share) | $ / shares   3.03 3.00 2.92      
Exercisable (in dollars per share) | $ / shares   $ 3.18 $ 3.03 $ 3.00   $ 3.18 $ 3.18
Weighted average remaining life in years              
Outstanding   1 year 8 months 23 days 2 years 6 months 14 days 3 years 5 months 26 days 4 years 2 months 26 days    
Exercisable   1 year 8 months 23 days 2 years 6 months 14 days 3 years 5 months 26 days      
2019 ISOP              
Changes In Equity Instruments, Number Of Equity Instruments, In Share-Based Payment Arrangement [Abstract]              
Outstanding at beginning of period (in shares)   2,308,760 2,402,510 2,629,516      
Granted (in shares)           0  
Exercised (in shares) 0 (40,373) (38,250) (32,000)      
Forfeited (in shares)   (15,000) (55,500) (195,006)      
Outstanding at end of period (in shares)   2,253,387 2,308,760 2,402,510 2,629,516 2,253,387 2,253,387
Exercisable (in shares)   2,253,367 2,033,490 1,651,493   2,253,367 2,253,367
Changes In Equity Instruments, Weighted Average Exercise Price Of Equity Instruemnts, In Share-Based Payment Arrangement [Abstract]              
Outstanding at end of period (in dollars per share) | $ / shares   $ 5.00 $ 4.97 $ 4.97 $ 4.96 $ 5.00 $ 5.00
Exercised (in dollars per share) | $ / shares   3.49 4.12 4.06      
Forfeited (in dollars per share) | $ / shares   5.06 5.46 4.94      
Outstanding at beginning of period (in dollars per share) | $ / shares   4.97 4.97 4.96      
Exercisable (in dollars per share) | $ / shares   $ 5.00 $ 4.80 $ 4.64   $ 5.00 $ 5.00
Weighted average remaining life in years              
Outstanding   4 years 5 months 1 day 5 years 4 months 24 days 6 years 3 months 18 days 7 years 2 months 15 days    
Exercisable   4 years 5 months 1 day 5 years 3 months 21 days 6 years 10 days      
2021 EIP              
Changes In Equity Instruments, Number Of Equity Instruments, In Share-Based Payment Arrangement [Abstract]              
Outstanding at beginning of period (in shares)   9,044,607 5,708,059 2,624,297      
Granted (in shares)   3,280,275 3,840,087 3,734,266      
Exercised (in shares)   (29,412) (49,119) 0      
Forfeited (in shares)   (909,956) (454,420) (645,310)      
Outstanding at end of period (in shares)   11,385,514 9,044,607 5,708,059 2,624,297 11,385,514 11,385,514
Exercisable (in shares)   4,989,270 2,806,356 1,155,231   4,989,270 4,989,270
Changes In Equity Instruments, Weighted Average Exercise Price Of Equity Instruemnts, In Share-Based Payment Arrangement [Abstract]              
Outstanding at end of period (in dollars per share) | $ / shares   $ 5.72 $ 6.69 $ 7.84 $ 12.32 $ 5.72 $ 5.72
Granted (in dollars per share) | $ / shares   3.29 4.78 4.44      
Exercised (in dollars per share) | $ / shares   2.78 2.87        
Forfeited (in dollars per share) | $ / shares   6.69 5.37 6.43      
Outstanding at beginning of period (in dollars per share) | $ / shares   6.69 7.84 12.32      
Exercisable (in dollars per share) | $ / shares   $ 7.97 $ 10.22 $ 14.64   $ 7.97 $ 7.97
Weighted average remaining life in years              
Outstanding   7 years 11 months 23 days 8 years 4 months 24 days 8 years 8 months 26 days 8 years 10 months 17 days    
Exercisable   7 years 1 month 9 days 7 years 4 months 13 days 7 years 6 months 25 days